The HOX11 proto-oncogene is normally expressed in embryogenesis where it directs the synthesis of the spleen. In adult tissues, HOX11 expression is silenced by an unknown mechanism. Aberrant expression of HOX11 occurs in T-cell acute lymphoblastic leukaemia (T-ALL), where it is thought to be involved in T-cell immortalization. The deregulated expression of HOX11 is frequently associated with chromosomal translocations which juxtapose a T-cell receptor (TCR) gene upstream of the HOX11 gene. In these cases, it is presumed that the activation of HOX11 expression results from bringing the gene under the control of TCR enhancer elements. However, activation of HOX11 also occurs in the absence of an associated translocation in both T-ALL and erythroleukaemia cells, implying that an alternative activation mechanism may exist. We hypothesized that HOX11 may be repressed in normal T-cells and erythroid cells by the action of negative elements which may be deleted or mutated in leukaemia. We therefore conducted a search for negative elements in the human HOX11 promoter which may function to silence its expression in normal cells of the haematopoietic lineages. Since little sequence of the HOX11 promoter was available, we began our investigation by sequencing over 4.5 kilobases of untranslated DNA from upstream of HOX11. The human sequence that overlaps with the 2.1 kb of murine Hox11 is highly conserved, suggesting that a large region of DNA upstream of HOX11 may have a regulatory function. We then used transfection assays to test the ability of portions of the promoter to drive transcription of a reporter gene. These studies identi®ed four negative elements. Two of them (NRE2 and NRE4) function in all cell lines tested, while the remaining two (NRE1 and NRE3) appear to be cell-type speci®c. The DNA sequences of three elements are conserved between the human and mouse HOX11/Hox11 promoters. We propose a model in which the combined action of these negative elements contributes to the overall repression of HOX11 expression in normal blood cells.
Introduction
Activation of oncogenes is frequently caused by gross chromosomal changes such as translocations (see Rabbitts, 1994 for review). A T-cell acute lymphoblastic leukaemia (T-ALL) cell line established in our laboratory, designated PER-255 (Kees et al., 1989) , was utilized to clone a breakpoint which identi®ed the HOX11 oncogene located at 10q24 (Kennedy et al., 1991) . HOX11 encodes a homeodomain-containing transcription factor which binds to a speci®c DNA sequence and is localized in the nucleus (Dear et al., 1993) . The normal function of the Hox11 protein is to direct the synthesis of the spleen during embryogenesis (Dear et al., 1995; Roberts, et al., 1994) . Subsequently, HOX11 expression is normally silenced in all tissues by adulthood. Deregulation of HOX11 immortalizes haematopoietic precursor cells (Hawley et al., 1994) , although induction of the fully malignant phenotype appears to require addition lesions. We have previously shown that deregulated expression of HOX11 occurs in a signi®cant proportion of childhood T-ALL and that expression of HOX11 is con®ned to T-ALL and does not occur in B-lineage ALL (Salvati et al., 1995) . Like most T-ALL oncogenes, HOX11 is not expressed in normal T-cells (Hatano et al., 1991; Salvati et al., 1995; Zutter et al., 1990) , although there is one report of HOX11 expression in T-cells (Lu et al., 1992) .
Several groups independently identi®ed HOX11 from sequencing breakpoints of various translocations involving the 10q24 locus. These translocations generally juxtapose the 5' untranslated region of HOX11 immediately downstream of the T-cell receptor genes, presumably bringing it under the control of positive transcriptional elements at these loci (DubeÂ et al., 1991; Kagan et al., 1989; Kagan et al., 1994; Kennedy et al., 1991; Lu et al., 1991; Zutter et al., 1990) . However, our studies suggested that HOX11 expression can be activated by mechanisms other than translocation (Salvati et al., 1995) . Detailed analyses of the HOX11 promoter have not yet been carried out. However, a recent study of the murine Hox11 promoter has provided evidence for a negative transcriptional element (Arai, et al., 1997) . We hypothesize that negative regulation of the human HOX11 gene may contribute to its repression in normal cells of the haematopoietic lineage. Loss of negative elements may be a feature of the transcriptional activation of HOX11 following translocation. Moreover, speci®c mutation or deletion of such negative elements in leukaemia patients may account for the activation of the gene in the absence of any translocation. Precedent for the activation of genes by promoter mutation can be found in hereditary persistence of foetal haemoglobin (HPFH), a condition which results in continued expression of foetal haemoglobin into adulthood due to either upstream deletion or promoter mutation (Motum et al., 1993) .
Many members of the homeobox family of genes are controlled by negative elements in their promoters. Some negative elements appear to act locally and/or in a tissue-or stage-speci®c manner while others can act over a large distance in a general manner (reviewed by Levine and Manley, 1989) . A special class of negative factors, including the polycomb family of Drosophila proteins acts globally to stably repress a large number of homeobox genes through negative elements in their promoters. These polycomb proteins are thought to form a DNA binding complex which remodels chromatin to a transcriptionally refractory state (for review see Bienz and MuÈ ller, 1995; Simon, 1995) . Related proteins include the products of the MLL and BMI-1 genes, which are implicated in human lymphoid malignancies and which positively and negatively regulate HOX gene expression, respectively (Alkema et al., 1995; Yu et al., 1995) . Translocation of the HOX11 gene into the TCR locus may remove longrange negative elements and place the gene in a transcriptionally active`open' chromatin milieu where it can be activated by nearby positive elements. In addition, mutation or deletion of negative elements may release the gene from short-range repression eects mediated by repressors acting locally. Negative regulation can be involved in both tissue-speci®c and stage-speci®c silencing of gene expression. For example, negative elements have been shown to contribute to the developmental silencing of the a-foetoprotein gene (Vacher and Tilghman, 1990) . In mice, a targeted mutation of a negative regulatory element between the Hoxd-11 and Hoxd-10 genes was shown to be sucient to alter the pattern of their expression and consequently eect the development of vertebrae in vivo (Gerard et al., 1996) . Precedent also exists for the repression of an oncogene promoter. For example, the cell type speci®city of the N-myc promoter in human neuroblastoma cells is mediated by a downstream silencer (Woodru et al., 1995) .
Since the human HOX11 promoter was uncharacterized, we embarked on a search for potential regulatory elements. Here we identify both positive and negative elements in the HOX11 promoter. We then focused on the characterization of the negative elements, since we were interested in the mechanism of HOX11 repression. These elements function in cell types which are both permissive and non-permissive for endogenous HOX11 gene expression. We propose a theory of tight repression of HOX11 expression in normal T-cells and erythroid cells, through the combined action of multiple negative elements.
Results
The human and mouse HOX11/Hox11 promoters are highly conserved Scant genomic sequence data for the human HOX11 promoter has been published and only about 1 kb of 5' noncoding sequence is available in the genomic databases (see Genbank accession No. M62626). We therefore cloned and sequenced approximately 5 kb of the HOX11 locus from normal human genomic DNA. This sequence has been deposited in the Genbank database (accession No AF067443). A schematic map of this region is shown in Figure 1a . When this sequence was used to search the available databases for large homologous open reading frames, it was found to contain no compelling evidence for genes additional to HOX11. (Arai et al., 1997) , revealed a surprising degree of homology over the 2.1 kb region of overlap. The regions of nucleotide conservation across the murine Hox11 promoter sequence are represented schematically in Figure 1b . There was over 70% nucleotide identity with the human HOX11 promoter over the entire available murine sequence. Moreover, numerous regions exist where the homology is greater than 90% over residue blocks of at least 40 bp. Based on this observation, it is unlikely that such a degree of homology would have been conserved in non-coding DNA unless it played a role in transcriptional control of HOX11. When the human HOX11 promoter sequence was used to search databases of cognate binding sites for transcription factors within the promoter region, homologies to numerous consensus sequences for transcription factor binding sites were found as expected. These include sequences implicated in the determination of transcriptional start sites, such as TATA boxes, Initiator (Smale and Baltimore, 1989; Weis and Reinberg, 1992) and MED1 elements (Ince and Scotto, 1995) . The functional signi®cance of these elements will be assessed in future studies. Consensus binding sites for multiple transcription factors previously implicated in both constitutive and inducible gene activation and repression were also found upstream of the HOX11 gene. For example, consensus sequences were identi®ed for the transcription factors: AP-1, SP1, CREB, ATF, ATF-3, Ets-1, GR and NF-kB, which comprise a combination of ubiquitous and tissue-speci®c transcription factors commonly found in mammalian promoters. However, to establish whether any of these sequences were indeed functional in regulating promoter activity, we tested the ability of various regions of the HOX11 promoter to drive transcription of a reporter gene in transfection assays.
Identi®cation of positive and negative elements in the HOX11 promoter A 4.8 kb DNA fragment containing the sequenced HOX11 promoter region, was cloned upstream of the luciferase reporter gene to generate the construct p(HOX11-5')- Figure 2 . In work to be presented elsewhere, we have mapped a leukaemia cell-speci®c transcriptional start-site within this region to a position approximately 50 base pairs (bp) upstream of the translational start ATG. This cap-site is consistent with a previously identi®ed transcriptional start point . In contrast to recent RNA mapping work in the murine system (Arai et al., 1997) , we have obtained no evidence for a corresponding human transcriptional start site at approximately 790 bp upstream of the HOX11 translation initiation codon. A series of deletion constructs was created from p(HOX11-5'); shown schematically on the left of Figure 2 . The series of constructs was then transfected transiently into both K562 cells (which expressed endogenous HOX11) and HEL cells (which failed to express HOX11), together with a cotransfection control constitutively expressing bgalactosidase for normalization of transfection efficiency. K562 cells (Lozzio and Lozzio, 1975 ) have a strongly embryonic phenotype (as evidence by production of large amounts of epsilon globin) (Miller et al., 1984) , while HEL cells (Martin and Papayannopoulou, 1982) have a mainly foetal phenotype with traces of Figure 2 The structure of the primary construct used in the deletion analysis p(HOX11-5') is shown above. The densely shaded bar on the left represents the HOX11 promoter (from 74796 bp) and 5' UTR respectively, and the ®lled in bar on the right indicates the luciferase gene fusion in p(HOX11-5'). The presumed start methionine for translational initiation of HOX11 expression is indicated as`ATG'. The constructs used in the primary transfection series are shown schematically underneath with noncoding DNA as hatched boxes and coding DNA as open boxes. Constructs all contain a small amount of the HOX11 open reading frame (to nucleotide #185 bp) fused to the luciferase gene. The results of primary deletion constructs transfected into K562 and HEL cells are shown graphically on the right hand portion of the ®gure. The mean results of at least three transfections using independent DNA preparations are shown. Error bars represent standard errors of the mean. Relative transcriptional activity is the ratio of luciferase activity to b-galactosidase activity (in arbitrary units) residual embryonic globin expression (Rutherford et al., 1981) . Following transfection and transient expression, the cell lysates were sequentially assayed for luciferase and b-galactosidase activity using luminometry. The results of multiple transfection experiments using independent DNA preparations are shown in Figure 2 . Constructs are named according to the deletion endpoint, relative to the HOX11 translational start codon (designated as +1). The shortest construct, designated p(+30), is the relevant negative control since it contains the HOX11 coding-region and vector sequences shared by all the other constructs, while lacking any promoter DNA. Overall the HOX11 promoter expression pro®les are similar between the two cell lines, with some pertinent dierences. A construct containing only 62 bp of DNA upstream of the translation start site had no signi®cant promoter activity over the negative control. In contrast, a construct with 669 bp of upstream non-coding DNA had signi®cant promoter activity in both K562 and HEL cell lines, implying the presence of transcriptional initiation elements and binding sites for positive transcription factors in the promoter region downstream of 7669 bp; compare transcriptional activity of constructs p(762) with p(7669). The presence of an additional 150 bp of promoter sequence in construct p(7819), had no signi®cant eect in K562 cells but allowed slightly increased expression in HEL cells, suggesting a stage-speci®c transcriptional activator may bind to the promoter between positions 7669 and 7819. Most notable was a sharp reduction in expression with the addition of 240 bp of promoter DNA in construct p(71059). This decrease in expression was observed in both K562 and HEL cells and demonstrates the presence of a negative element (NRE2) between positions 7819 and 71059. A rise in transcriptional activity with 1001 bp of additional sequence demonstrates the presence of a K562-speci®c positive element between 71059 and 72060 bp. A fall in transcriptional activity with further addition of 1730 bp, highlights the presence of a distal negative element (NRE1) between 72060 and 73790. This distal negative element apparently functions in HEL cells, but has no signi®cant eect in K562 cells which are thought to correspond to an earlier maturation stage. The further de®nition of this element will not be described here. The apparent speci®city of this distal negative element to a slightly later maturation stage, may be important for developmental extinction of HOX11 expression (see Discussion). Since our goal was to characterize sequences responsible for repression of HOX11 in normal cells, we decided to concentrate on the further de®nition of the negative rather than positive elements identi®ed in the preceding analysis. As a starting point we began with the proximal negative elements which lay closest to the transcriptional initiation site.
De®nition of the proximal negative elements
In order to de®ne the proximal negative element more precisely, we constructed a nested series of 5'-truncation mutants of the shortest construct which had previously been found to contain NRE2, i.e. p(71059). The left side of Figure 3 shows schematically the end-points of these mutants, which were constructed using exonuclease-III digestion. These mutants were transfected into K562 cells which had previously been shown to respond to NRE2. In addition, the same series of mutant constructs was transfected into the HOX11-negative T-ALL cell line PER-117 (Kees et al., 1987) , in order to test the hypothesis that the repressor binding NRE2, was present in T-cells as well as in erythroid cells. The results of these experiments are presented in Figure 3 . In both cell lines, the removal of only 59 bp resulted in a large increase in transcriptional activity Ð compare construct p(71059) with construct p(71000). This result de®nes the 5' boundary of the negative element NRE2 to the 59 bp region of the promoter between these deletion endpoints.
Deletions p(7819) and p(7857) also provide evidence for a further, apparently weak negative element (NRE3) which only functions in PER-117 cells and not K562 (Figure 3) . Deletion of sequences between p(7754) to p(7669) however, produces a large increase in transcriptional activity in both cell lines. This results from the removal of a novel strong negative element (NRE4) in the proximal region of the HOX11 promoter which functions in both erythroid and lymphoid cells. These deletion analyses have allowed the re®nement of the 5' boundaries of NRE3 and NRE4 to within a 38 bp and 85 bp region, respectively. The sequence of the proximal negative elements described above are conserved between the human and murine HOX11/Hox11 promoter sequence (see Discussion).
Discussion

Sequencing the HOX11 promoter
We chose to begin the characterization of the HOX11 promoter by sequencing several kilobases of 5' noncoding DNA. This suggested that there were no additional genes immediately upstream of HOX11. In addition the new sequence data highlighted a range of potential transcription factor binding sites as expected. Many of these sites corresponded well with those found in other mammalian homeobox promoters such as Hox-B3 (Brown and Taylor, 1994) . Consensus binding sites for known transcriptional activators and repressors were identi®ed in the analysis. The HOX11 sequence data provided a useful basis for the subsequent generation and characterization of a family of nested deletions of the HOX11 promoter. This study led to the identi®cation of several negative elements based on the functional analysis of deletion mutants.
Stage-speci®c and general silencing of HOX11 expression via multiple negative elements
In an attempt to explain how the HOX11 gene is kept repressed in normal cells, we embarked on a search for negative elements in the human HOX11 promoter. We have identi®ed two such negative elements (NRE2) and (NRE4) which function in cell lines which either express (K562) and do not normally express (PER-117, HEL) endogenous HOX11. It should be noted that NRE4 could not be detected in the initial broad deletion series described in Figure 2 . Presumably the identi®cation of NRE4 was masked in the larger deletion, by the concomitant removal of positive elements which compensated for its removal of NRE4. We have also identi®ed two negative elements (NRE1) and (NRE3) which do not function in K562 cells, but are clearly operational in the more mature erythroid line HEL. The relative positions of the proximal negative elements in the HOX11 promoter are outlined schematically in Figure 4a , and the cell type speci®city of each element is shown in Table 1 . Normal activation of HOX11 at the embryonic stage of development could occur through the action of stage-speci®c transcriptional activators present in the embryo. It is also possible that the subsequent appearance of a repressor later in development, initiates the HOX11 silencing process in a broad range of cell types. Such developmental silencing of homeobox genes has been described in Drosophila (reviewed by Gray and Levine, 1996) . We have de®ned the proximal negative elements further by deletion analysis, having localized the 5' boundaries of NRE2, NRE3 and NRE4 to within a 59 bp, 38 bp and 85 bp sequence, respectively.
Proximal negative elements are conserved between the human and murine HOX11/Hox11 promoter sequences
Comparison between human and mouse sequence was possible for three of the four negative elements de®ned here. However, the available murine Hox11 sequence does not extend to the region containing NRE1, making comparison impossible. It is unclear whether any relationship exists between our ®ndings and those from another group who recently reported a negative element upstream of the murine Hox11 gene (Arai et al., 1997) . This negative element was reported to be located within a region between 71240 and 7540 bp of the murine gene and further de®nition of the position was not undertaken. However, alignment of the three proximal negative elements de®ned in this study to the murine sequence (shown in Figure 4b ), revealed extensive homology of NRE3 (92% identity) and NRE4 (86% identity), and a lesser degree of homology within NRE2 (51%). To identify any known transcription factors which have the potential to bind these negative elements, we used their sequences to search databases of transcription factor binding sites. It is potentially relevant that the NRE2 sequence contains a consensus binding site (ATTTTA) for F2F, a transcription factor responsible for repression of the prolactin gene in non-pituitary cells (Jackson et al., 1992) . There is an apparent lack of conservation of the F2F sequence between the human and mouse HOX11/ Hox11 sequences, suggesting that the element may not play a signi®cant role, or alternatively, that regulation via F2F may be speci®c to the human gene. NRE3 contains a consensus (CA/CGTTPu) binding site for cMyb (Howe et al., 1990) . c-Myb is expressed in cells of the haematopoietic lineages (Sullivan et al., 1997) , where it has been shown to play a role in negative as well as positive regulation (Guerra, et al., 1995; Nakagoshi et al, 1989) . In addition, the NRE4 sequence contains a conserved binding motif (TGAGTG) (Biggin and Tjian, 1989) for Zeste, a Drosophila transcription factor (Laney and Biggin, 1996; Pirrotta, 1991) which has mammalian homologues (Hughes et al., 1993) . The signi®cance of the above binding sites could be assessed by transactivation assays in cell lines conditionally coexpressing the relevant transcription factors together with mutant and wild-type HOX11 reporter constructs.
A model for silencing of HOX11 expression in normal cells of the haematopoietic lineages
We have recently identi®ed a cluster of molecular aberrations in paediatric T-ALL specimens positive for HOX11 expression yet lacking a chromosomal translocation involving 10q24 (Salvati et al., 1995 and data not shown) . Intriguingly, evidence suggests that several of these aberrations map to a region which includes the negative elements identi®ed here. The further analysis of these patient specimens and subsequent analysis of the abnormal alleles by PCR ± SSC and sequencing, will help to establish whether mutation of NRE2, NRE3 and/or NRE4 is sucient for activation of HOX11 expression in vivo. Consistent with such a hypothesis is our observation that the proximal negative elements function in the T-ALL cell line PER-117, which does not express HOX11 endogenously. There is precedent for activation of an oncogene by promoter mutations in the absence of cytogenetic aberrations. For example, we have observed the activation of MYC-family genes in the absence of abnormal cytogenetics or gene ampli®cation (Kees et al., 1994 (Kees et al., , 1998 . Moreover, expression of the TAL1/SCL proto-oncogene is reported to be deregulated in T-ALL without translocation or gross deletion (Bash et al., 1995; Bernard et al., 1992; Macintyre 1992) . This result suggests that a mechanism other than juxtaposition to the SIL gene by upstream deletion, or translocation to the TCR could sometimes be responsible for TAL1/SCL activation. While this Cell-type speci®city of cell lines PER-117, HEL and K562 (indicated on the left). The second column from the left indenti®es the cell lines in which expression of the 2.3 kb HOX11 transcript is detectable (+) or not detectabe (-) in Northern blotting and Ribonuclease Protection Assays (data not shown). In the other columns, the symbol (+) represents repressional activity, while the symbol (±) represents inactivity of the repressor sequence or activation. ND: not determined activation could be due to mutations which allow positive transcription factor binding, the possibility also exists that negative elements have been mutated or deleted entirely, rendering them insensitive to their cognate repressors. Indeed a very recent study identi®ed several lineage speci®c chromatin dependent silencers in the TAL1/SCL promoter (Gottgens et al., 1997) which could, in principle, be targets for promoter mutations in leukaemia. The activity of NRE1 and NRE3 in HEL cells (which do not express HOX11), in contrast to its apparent inactivity in K562 cells, (which express HOX11, and have a fully embryonic phenotype) is compatible with NRE1/NRE3 playing a role in the silencing of HOX11 expression after the embryonic stage of development. According to this model, NRE1/ NRE3 binding repressor(s) would accumulate in cells with a post-embryonic phenotype, contributing to the shut-down of HOX11 expression observed in those cells (see above). It remains an interesting possibility that the removal of one or more of these negative elements by the majority of T-ALL translocations involving HOX11 (Kagan et al., 1994) , may contribute to the activation of the gene in T-ALL.
Full repression can require the action of several distinct negative elements. Indeed, multiple negative elements have been observed in other mammalian homeobox genes such as Hoxb-4 (Gutman, et al, 1994) and modular silencers with cumulative or synergistic eects have been observed in other genes such as the rat glutathione transferase P gene (Imagawa et al., 1991) the chicken lysozyme gene (Baniahmad et al., 1990) , and the human b-interferon gene (Goodbourn, et al., 1986; Goodbourn and Maniatis, 1988) . The initiation of silencing at one or more of the negative elements in the HOX11 promoter described here may subsequently allow the establishment of a heritable, fully repressive, chromatin structure through the action of ubiquitous proteins, such as those belonging to the polycomb-group (see Kingston et al., 1996, for review) . This model is consistent with existing theories for homeobox gene silencing in Drosophila, which postulate several layers of repression. For example in Drosophila, distinct negative elements control the establishment and maintenance of repression (see Bienz and MuÈ ller, 1995; Gray and Levine, 1996; Ip and Hemavathy, 1997) . Clearly, given the oncogenic potential of proteins involved in cellular proliferation/apoptosis such as HOX11, there would exist a strong selection for the generation of highly ecient mechanisms for ensuring complete extinction of their gene expression. Moreover, the functional redundancy allowed by multiple negative elements may help to ensure that the associated gene is not fully derepressed by a single mutation. Since these initial investigations are based on deletion analyses which concomitantly remove positive elements, together with negative elements, it is not possible to determine the degree of repression mediated by these negative elements in their normal context. Future investigations using site-directed mutagenesis and stable transfection of large constructs will clarify the extent to which NRE1, NRE2, NRE3 and NRE4 individually contribute to the overall repression of HOX11. Combinatorial mutation in such studies will help to determine the combined role of these novel regulatory elements in maintaining repression of HOX11 expression in normal cells.
Materials and methods
Plasmid construction
The start sites of transcription and translation of the HOX11 gene have been predicted from available sequence data. The largest parent HOX11 construct was designed to include 185 bp of the putative coding region of the HOX11 gene. Maintenance of distance from the Kozak consensus sequence by including a buer region of non-coding DNA ensured that deletion eects were unlikely to result from dierences in translation eciency. To construct p(HOX11-5'), a 4.8 kb NotI ± BamHI restriction fragment from the 5' regulatory region of the HOX11 gene was isolated from a PAC clone obtained from a normal genomic library (courtesy Dr Roger Cox., Wellcome Centre for Human Genetics, Oxford) and subcloned into a BglII ± NotIdigested, modi®ed form of pGL3-basic (pGL3-basicDNotI). The plasmid pGL3-basicDNotI was constructed as follows: pGL3-Basic (Promega corporation, USA) was digested with the restriction enzyme NotI (a site present within the f1 origin of replication). The 5' overhangs from this digestion were then ®lled in with Klenow polymerase and the vector religated to remove the NotI site. The modi®ed pGL3-Basic was then digested with HindIII and a double stranded oligonucleotide (DNotI) was inserted which restored a unique NotI site 3' of the MCS. The sequence of DNotI is :5'-AGC TGC GGC CGC-3' (creates a new NotI site).
The ®rst set of deletion constructs were made from p(HOX11-5') as follows: To generate smaller fragments of the 5' HOX11 insert, use was made of existing restriction enzyme recognition sites within the multiple cloning site of the modi®ed vector of p(HOX11-5'), and within the 5' HOX11 fragment itself. Internal deletions removed 5' fragments of the HOX11 insert to enable re-ligation to the MCS of the vector. (p+30) was generated by the digestion of p(HOX11-5') with XmaI; p(762) with NheI; p(7669) with PvuII; p(7819) digested with StuI; p(71059) with EcoRI; p(72060) with Ecl136II and p(73790) with Acc65I. The endpoints of all deletion mutants were con®rmed by sequencing.
Preparation of nested deletion series using exonuclease III
The deletion mutants used in this re®nement were generated by timed exposure to exonuclease III. The DNA template of the exonuclease III digestion series was deletion mutant (p72060). End points of the deletion re®nements lay between 71059 to 7669 bp. The basic protocol for exonuclease III digestion was provided by the Erase-a-Base 1 system (Promega, USA) and is described in (Ausubel et al., 1998) . Speci®cally, the DNA template was digested with KpnI and EcoRI and gel-puri®ed. Exonuclease III digestions were performed at 228C with 175 units of exo-nuclease III and 8 mg of puri®ed template. Aliquots were removed at 30 s intervals and the reaction stopped by the addition of EDTA and the products puri®ed, prior to treatment with S1 nuclease to remove single stranded DNA. Aliquots which had digested to an appropriate degree (as determined by gel electrophoresis following digestion) were then religated and transformed to recover mutants. The endpoints of all deletion mutants were con®rmed by sequencing.
DNA sequencing and database searching
Sequencing of constructs was performed with the Applied Biosystems 373 cycle sequencer (Perkin Elmer), using the ABI prism dye terminator cycle sequencing kit (Perkin Elmer).
Searches for potential transcription factor binding sites were performed with both the TESS algorithm against the TRANSFAC database and using MacVector (Oxford Molecular Group) subsequent searching software.
Preparation of DNA for transfections
For all transfections into eukaryotic cell lines, DNA from each construct was prepared by two methods. (A) Alkali lysis, followed by anion exchange puri®cation: These preparations were made using the Bresapure plasmid puri®cation kit-based systems (Bresatec, Australia) according to the manufacturer's instructions. The plasmid yield being between 0.5 ± 2.0 mg was resuspended in ddH 2 O to give a working concentration of 2.0 ± 4.0 mg/ml. (B) Cesium chloride density gradient puri®cation: These preparations were made using the protocol as described in (Ausubel et al., 1998) .
Cell culture and transfections
K562 (Lozzio and Lozzio, 1975) and HEL-900 (Martin and Papayannopoulou, 1982) cell lines were grown in RPMI containing 0.03% w/v L-glutamine+10% foetal calf serum, at 378C in a humidi®ed atmosphere with 5% CO 2 . The PER-117 (Kees et al., 1987) cell line was grown similarly except for the addition of 0.03% pyruvate and 0.03% nonessential amino acids to the media. Cultured cells were grown to a density of 5 ± 6610 5 /ml. Each transfection used 1610 7 cells. Prior to their transfection the cells were washed twice in 5 ml of RPMI (centrifugation at 1500 r.p.m. for 5 min in a Hettich universal centrifuge, 1323 rotor) and resuspended in 400 ml of the same solution. After incubating the cells at room temperature for 10 min, electroporation was performed using the Gene Pulser (BioRad), set at 300 V, 960 mF capacitance. Transfections contained 20 mg of test plasmid and 5 mg of control plasmid in a 0.4 centimetre gap electroporation cuvette (BioRad or Invitrogen). After electroporation, the cells were incubated at room temperature for 10 min and then resuspended in 7 ml of growth media and incubated at 378C in 5% CO 2 for 24 ± 26 h. All transfections were performed at least three times with at least two independent DNA preparations.
Luciferase and b-galactosidase reporter gene assays Dual Light luminescent detection kit (Tropix, Perkin Elmer) was used for detection of both luciferase and bgalactosidase activity from the same lysate sample. This detection system has a large linear range for luciferase concentrations (between 10 715 to 10 78 g) and for bgalactosidase concentrations (between 10 713 to 10 79 g) (Martin et al., 1996) . Nevertheless, titration experiments were performed to ensure that linearity standards were maintained in our system. Post transfection, the transfected cells were washed three times in 5 ml of phosphate buered saline (PBS) (centrifugation at 1500 r.p.m. for 5 min). After the ®nal wash the excess¯uid was removed and the cells resuspended in 250 ml of Dual Light kit lysis solution (Tropix, Perkin Elmer) containing freshly added 0.5 mM DTT. The cells were lysed by vigorous pipetting and debris pelleted by centrifugation at 13 000 r.p.m. for 5 min (Beckman, microfuge). The cell lysate was then assayed immediately or stored at 770 8C. The assay cell lysate was diluted 1:2 with freshly prepared lysis solution (Tropix, Perkin Elmer) containing 0.5 mM DTT. 10 ml of the 1:2 dilution was then assayed in an opaque 96 well microtitre plate (Evergreen, Wallac, Finland) according to the manufacturer's instructions. The relative light units (RLU) of the luciferase reaction were then read in counts per second (c.p.s.) using the Victor TM 1420 multi-label counter and associated computer software (Wallac, Finland). The microtitre plate was then incubated at room temperature in the dark for exactly 40 min before the addition of 100 ml of Accelerator II which facilitates the bgalactosidase reaction. Again light emission was measured in RLUs in c.p.s. using the same multi-label counter. Results obtained with the Dual Light luminescent detection system correlated well with independent luciferase assays using o-nitrophenyl-b-galactopyranoside (ONPG) as the bgalactosidase substrate.
